WanaBana Lead Applesauce Lawsuits in 2026: The $559,250 Penalty, the Bankruptcy Problem, and Who Can Still File

In late 2023, routine blood tests found elevated lead levels in toddlers across America — all traced to WanaBana apple cinnamon fruit puree pouches. A nationwide recall followed, the FDA uncovered deliberate cinnamon adulteration, and lawsuits began. In January 2026, Dollar Tree paid $559,250 to New York for selling the recalled pouches after the recall began. Individual claims are still being filed — but WanaBana's bankruptcy has reshaped who can pay.

Key Facts

  • October 29, 2023: WanaBana USA began a nationwide voluntary recall of its Apple Cinnamon Fruit Puree pouches after FDA testing found "extremely high concentrations of lead" in multiple lots.
  • 200+ adverse-event reports reached the FDA's CAERS system by March 2024, with 90 confirmed as involving elevated blood-lead levels as of January 31, 2024.
  • June 11, 2024: the FDA issued Dollar Tree a warning letter for continuing to sell recalled pouches — products were still on shelves as late as December 19, 2023, nearly two months after the recall.
  • January 23, 2026: Dollar Tree agreed to pay $559,250 in penalties to New York, where investigators found at least 226 three-pack units sold after the recall notice.
  • May 2024: WanaBana filed for Chapter 7 bankruptcy — a liquidation that has complicated recovery from the manufacturer itself.

How a Toddler's Snack Became a Federal Investigation

The story began in autumn 2023, when North Carolina health officials investigated four children with elevated blood-lead levels and found one common thread: WanaBana Apple Cinnamon Fruit Puree pouches. FDA laboratory testing confirmed what the agency called extremely high concentrations of lead, at levels it said could cause acute lead toxicity in children. The October 29, 2023 voluntary recall covered all lots, and the FDA later widened the net to private-label cinnamon applesauce pouches sold at Schnucks and Weis Markets, which shared the same contaminated cinnamon supply chain. The most unsettling detail: these were pouches marketed largely for babies and young children — the group most vulnerable to lead's effects on developing brains.

Why the Lead Was There: Economically Motivated Adulteration

The FDA traced the contamination to the cinnamon — specifically, ground cinnamon adulterated with lead chromate, a toxic compound sometimes used to deepen color and add weight. Economically motivated adulteration is the FDA's term for deliberately altering a food ingredient to increase profit, and the agency concluded that is what happened here. The trail pointed to Ecuador: in June 2024 the FDA placed Negasmart, the Ecuadorian cinnamon distributor, under two import alerts — one for heavy-metal contamination, one for products adulterated for economic gain — and in August 2024 issued a warning letter to Austrofood, the Ecuador-based manufacturer of the pouches. The contamination appears to have been a cost-cutting choice made somewhere upstream, not an accident of nature.

Dollar Tree's Role — and Its $559,250 Penalty

Dollar Tree was the largest U.S. seller of the pouches, and its handling of the recall drew federal and state fire. The FDA's June 2024 warning letter accused the retailer of continuing to offer recalled pouches on store shelves after being notified, noting that merely blocking the item at the register was insufficient when pouches were still sitting where customers could take them home. Audit checks found the products on shelves as late as December 19, 2023.

That history produced 2026's headline development. On January 23, 2026, New York Attorney General Letitia James announced a settlement requiring Dollar Tree to pay $559,250 in penalties, after investigators found the company sold at least 226 three-pack units of the contaminated product in New York after receiving the recall notice — sales continuing for up to a week. Dollar Tree must also overhaul its New York recall procedures, including register stop-codes within hours of a recall notice and enhanced manager training. The penalty money is earmarked for lead-poisoning prevention programs and healthy-food access in underserved communities. Dollar Tree is additionally a co-defendant in the pending personal-injury litigation — a fact that matters enormously given what happened to the manufacturer.

Where the Lawsuits Stand in Late 2026

The litigation has proceeded as individual personal-injury lawsuits rather than one class action. A federal court approved a settlement for one minor plaintiff in 2025, closing that family's claim, though the public docket discloses neither the defendants covered nor the dollar amount. No other settlement or verdict has been confirmed publicly. Plaintiffs seeking a class-wide medical-monitoring remedy hit a wall: a magistrate judge found the proposed class unworkable, noting the plaintiffs' own expert acknowledged that comprehensive neuropsychological evaluations would be needed child by child before determining treatment or monitoring. The practical message: these claims will be litigated on individual proof, not resolved in one stroke. That says nothing about whether the contamination occurred — the FDA's findings on that point are public record.

The Bankruptcy Problem

In May 2024, WanaBana filed for Chapter 7 bankruptcy. Chapter 7 is a liquidation process — unlike Chapter 11, there is no restructuring plan; the company sells its assets and proceeds go to creditors in a fixed legal order. For injured families, that is grim: the manufacturer at the center of the contamination may have little left to pay. This is precisely why Dollar Tree's presence as a co-defendant matters. A solvent retailer that allegedly kept selling a recalled children's product after the recall notice is, from a plaintiff's perspective, a far more viable source of recovery than a liquidated manufacturer.

Who Can Still File — and What a Case Needs

Eligibility turns on a short chain of proof: the child consumed one of the recalled pouches — WanaBana Apple Cinnamon Fruit Puree or the recalled Schnucks or Weis cinnamon applesauce pouches — and was subsequently found to have elevated blood-lead levels. Families who kept receipts, packaging, or purchase records are strongest, but bank and store-loyalty records can reconstruct purchases. The most persuasive files add blood-lead test results from the exposure period and pediatric records showing follow-up testing or developmental assessments.

Time limits vary by state, and many states pause the clock for minors — so a family that assumes it is too late may be wrong. Most firms handling these cases work on contingency, meaning they are paid only from a recovery, so an initial review typically costs nothing. For context on how recall-driven injury litigation unfolds, see the Philips CPAP recall lawsuit status and the NEC baby formula lawsuit deadlines; our guide to pre-settlement lawsuit loans breaks down the financing math honestly. For video explainers on consumer-protection topics, visit our Problem Solved channel.

This article is general information about litigation developments, not legal or financial advice. If your child may have been affected, consult a qualified attorney in your state.

Who Benefits From This — and Who Does Not

WanaBana claims are now litigated on individual proof, not resolved in one stroke — so who benefits turns on the proof chain, the clock, and which defendant can actually pay.

Who benefits:

  • Families whose child consumed a recalled pouch and was found to have elevated blood-lead levels: How: Build the short chain the article sets out — the recalled WanaBana Apple Cinnamon Fruit Puree or the recalled Schnucks or Weis cinnamon applesauce pouches, plus blood-lead test results from the exposure period and pediatric records showing follow-up testing or developmental assessments; receipts, packaging, bank records, or store-loyalty records can reconstruct purchases.
  • Families who assume it may be too late: How: Check the deadline anyway — time limits vary by state and many states pause the clock for minors, so a family that assumes it is too late may be wrong.
  • Families looking to a defendant who can actually pay: How: Note that Dollar Tree is a co-defendant in the pending personal-injury litigation and, after its January 23, 2026 agreement to pay $559,250 in penalties to New York for post-recall sales, must overhaul its New York recall procedures — a far more viable source of recovery than the liquidated manufacturer.

Who benefits little or not at all:

  • Families expecting a class-wide medical-monitoring remedy: A magistrate judge found the proposed class unworkable, noting the plaintiffs' own expert acknowledged that comprehensive neuropsychological evaluations would be needed child by child before determining treatment or monitoring.
  • Families expecting recovery from WanaBana itself: WanaBana filed for Chapter 7 bankruptcy in May 2024 — a liquidation in which the company sells its assets and proceeds go to creditors in a fixed legal order, leaving the manufacturer with little left to pay.
  • Families without the consumption-plus-levels chain: Eligibility turns on that chain: a recalled pouch consumed, followed by elevated blood-lead levels. Without both links, there is little to file.

Read more: Applesauce lead poisoning lawsuits in 2026: children, recalls, and claims

Frequently Asked Questions

Is there a WanaBana applesauce settlement I can join?

A federal court approved one settlement for a single minor plaintiff, but its terms are not public and there is no open class settlement to join. Remaining claims are pursued as individual lawsuits — joining means filing your own claim.

Can I still file a WanaBana lawsuit in 2026?

Possibly. Individual cases are still being filed, and statutes of limitation vary by state, with many pausing the clock for minors. Because WanaBana is in Chapter 7 bankruptcy, most active claims target co-defendants such as Dollar Tree.

What caused the lead contamination?

The FDA concluded the cinnamon was deliberately adulterated with lead chromate — economically motivated adulteration for profit. The agency placed the Ecuadorian distributor Negasmart under import alerts in June 2024 and issued the manufacturer Austrofood a warning letter that August.

What did Dollar Tree do wrong?

Per the FDA and the New York Attorney General, Dollar Tree kept selling recalled pouches after the October 29, 2023 recall notice — products were found on shelves as late as December 19, 2023. In January 2026 it paid $559,250 in penalties to New York and agreed to overhaul its recall procedures.

Who benefits from a WanaBana claim in 2026 — and who does not?

Families whose child consumed a recalled WanaBana, Schnucks, or Weis pouch and was found to have elevated blood-lead levels benefit most, especially with receipts or purchase records plus blood-lead results and pediatric follow-up records. Families who assume it is too late may also benefit, since many states pause the clock for minors. Families expecting a class-wide medical-monitoring remedy or recovery from WanaBana itself benefit little: the proposed class was found unworkable, and WanaBana's May 2024 Chapter 7 liquidation leaves the manufacturer with little to pay — which is why Dollar Tree's presence as a co-defendant matters.

How does a family start a WanaBana claim?

Gather the proof chain first: receipts, packaging, bank or store-loyalty records showing a recalled pouch purchase, blood-lead test results from the exposure period, and pediatric records of follow-up testing or developmental assessments. Then get a case review promptly — most firms handling these cases work on contingency, so an initial review typically costs nothing — and do not assume the deadline has passed, since many states pause the clock for minors.

Watch on YouTube

Problem Solved on YouTube